Tiziana Life Sciences Ltd
NASDAQ:TLSA
Income Statement
Earnings Waterfall
Tiziana Life Sciences Ltd
Revenue
|
0
USD
|
Operating Expenses
|
-14.6m
USD
|
Operating Income
|
-14.6m
USD
|
Other Expenses
|
-810k
USD
|
Net Income
|
-15.4m
USD
|
Income Statement
Tiziana Life Sciences Ltd
Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Gross Profit | ||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||
Operating Expenses |
(13)
|
(10)
|
(10)
|
(11)
|
(11)
|
(11)
|
(10)
|
(9)
|
(10)
|
(10)
|
(30)
|
(43)
|
(27)
|
(14)
|
(15)
|
|
Research & Development |
(10)
|
(6)
|
(4)
|
(6)
|
(6)
|
(6)
|
(6)
|
(4)
|
(4)
|
(3)
|
(6)
|
(11)
|
(13)
|
(15)
|
(13)
|
|
Other Operating Expenses |
(4)
|
(4)
|
(6)
|
(6)
|
(5)
|
(5)
|
(4)
|
(5)
|
(6)
|
(7)
|
(24)
|
(32)
|
(14)
|
0
|
(2)
|
|
Operating Income |
(13)
N/A
|
(10)
+22%
|
(10)
+4%
|
(11)
-17%
|
(11)
+7%
|
(11)
-4%
|
(10)
+11%
|
(9)
+6%
|
(10)
-7%
|
(10)
-2%
|
(30)
-201%
|
(43)
-42%
|
(27)
+37%
|
(14)
+47%
|
(15)
-1%
|
|
Pre-Tax Income | ||||||||||||||||
Interest Income Expense |
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
(1)
|
|
Pre-Tax Income |
(13)
N/A
|
(10)
+25%
|
(10)
+1%
|
(12)
-17%
|
(11)
+8%
|
(11)
-4%
|
(10)
+11%
|
(9)
+6%
|
(10)
-8%
|
(10)
-1%
|
(28)
-179%
|
(41)
-45%
|
(27)
+35%
|
(14)
+49%
|
(15)
-12%
|
|
Net Income | ||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
1
|
1
|
2
|
2
|
3
|
3
|
0
|
|
Income from Continuing Operations |
(13)
|
(10)
|
(10)
|
(11)
|
(9)
|
(9)
|
(8)
|
(7)
|
(9)
|
(10)
|
(26)
|
(39)
|
(23)
|
(10)
|
(15)
|
|
Net Income (Common) |
(13)
N/A
|
(10)
+25%
|
(10)
+2%
|
(11)
-17%
|
(9)
+23%
|
(9)
-5%
|
(8)
+13%
|
(7)
+7%
|
(9)
-26%
|
(10)
-2%
|
(26)
-174%
|
(39)
-49%
|
(23)
+40%
|
(10)
+55%
|
(15)
-47%
|
|
EPS (Diluted) |
-0.03
N/A
|
-0.02
+33%
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.03
-50%
|
-0.05
-67%
|
-0.05
N/A
|
-0.05
N/A
|
-0.06
-20%
|
-0.31
-417%
|
-0.51
-65%
|
-0.24
+53%
|
-0.1
+58%
|
-0.15
-50%
|